Building a Business > Intellectual property > archive

Trendspotting: a shift in intellectual property focus
April 2006

Building a strategy for maximizing intellectual property value
January 2005
Without a strategy to guide the development of their IP portfolios, companies may waste valuable resources and miss opportunities to protect valuable inventions.

Protecting your investment
April 2004
Life science entrepreneurs should establish a strong intellectual property position before seeking out investors.

The patent gamble: strategic insights for playing the worldwide patent game
October 2003
Biotech companies face the challenge of cutting costs to make their resources last through the economic downturn, while continuing to seek international patent protection for their inventions to ensure long-term viability.

Protecting innovation in biotechnology startups
June 2003
A solid understanding of the myriad IP issues faced by biotech startups is essential to the long-term viability of these companies.

Licensing research tool patents
September 2002
Patent holders often seek royalties on the sales of products developed using their tools, but how broadly should "reach-through" claims be applied?

Integrating the intellectual property value chain
June 2002
Biotechnology companies can use "value-chain analysis" to create processes for maximizing the value of their intellectual property portfolios, say Bill Barrett and Dave Crawford.

Defensive use of publications in an intellectual property strategy
February 2002
Although it has been slow to catch on in biotechnology, defensive publication can be an important part of your comprehensive IP strategy.

License and collaboration agreements: Protecting your most valuable asset
January 2002
Successful dealmaking will rely heavily on effectively exploiting your intellectual property rights.

Research tool patents: tips for facing a "pay up now or litigate" ultimatum
November 2001
When holders of research tool patents seeking exorbitant license fees threaten litigation, companies need not rush to accept a license without weighing their options.

Going for the big one
September 2001
Blockbuster patents enrich university coffers, but can also affect future patenting and research decisions.

Creating a winning patent portfolio
June 2001
Investors judge a biotechnology company on the basis of its patent portfolio, and companies are advised to ensure that it is watertight.

Patent due diligence in biotechnology transactions
March 2001
A due diligence review may be your most important tool in assessing and reducing the risks associated with a business transaction.

Patent due diligence in biotechnology transactions
February 2001
A thorough review of a company's IP assets may determine whether a business transaction will go forward.

Maximizing profits through intelligent planning and implementation
May 2000
What every executive needs to know about intellectual asset management.